Those that follow my articles know that I tend to focus mainly on undervalued microcap or smallcap biotech companies. A lot of my …
I have written a lot of articles over the years concerning my biotech investments and thankfully have done pretty well anticipating good entry …
When investing in biotech companies, I try to find undervalued companies with low-risk upcoming catalysts. For example, several months ago when Medivation (NASDAQ:MDVN) …
I wrote an article last week detailing why investors should buy MEI Pharma Inc (NASDAQ:MEIP) before the American Society of Hematology (ASH) meeting on Decemeber …
It would be an understatement to say the last few weeks have been harsh for biotech investors. However, I have used the dip …
After hitting a high of $140 per share in March, Medivation Inc (NASDAQ:MDVN) has been on a downward trend despite nothing but good …
Those that follow my biotech recommendations know that I look for undervalued small cap stocks with significant upside. Some may be momentum plays, …
In today’s market with most biotech companies sporting bloated valuations it can be hard for investors to find stocks with significant upside. I …
Medivation Inc (NASDAQ:MDVN) has been in a free fall ever since the ASCO conference at the beginning of June, losing over 20% of its …
My investment strategy is simple. Find small-cap undervalued biotech companies with promising drugs and significant short and long term upside.
